Page last updated: 2024-10-17

bupropion and Autosomal Dominant Juvenile Parkinson Disease

bupropion has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalho, MM1
Campos, FL1
Coimbra, B1
Pêgo, JM1
Rodrigues, C1
Lima, R1
Rodrigues, AJ1
Sousa, N1
Salgado, AJ1
Jerome, L1

Other Studies

2 other studies available for bupropion and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.
    Molecular neurodegeneration, 2013, Apr-26, Volume: 8

    Topics: Adrenergic Agents; Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Bupropion

2013
Bupropion and drug-induced parkinsonism.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:6

    Topics: Bupropion; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Male; M

2001